{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:59:52Z","timestamp":1790398792726,"version":"4.1.0"},"reference-count":42,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.5582\/ddt.2026.01045","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:11:17Z","timestamp":1787695877000},"page":"293-308","source":"Crossref","is-referenced-by-count":0,"title":["Duzhong Fang (DZF) alleviates rotenone-induced Parkinson's disease-like pathological alterations through regulation of the gut-brain axis &lt;i&gt;via&lt;\/i&gt; the intestinal TPH1\/5-HT pathway"],"prefix":"10.5582","volume":"20","author":[{"given":"LiLi","family":"Li","sequence":"first","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anran","family":"Lv","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibao","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiran","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishu","family":"Yan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Tian","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jia","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China."},{"name":"National Clinical Research Center for Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Zhuang","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China."},{"name":"National Clinical Research Center for Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jankovic J, Tan EK. Parkinson&apos;s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020; 91:795-808.","DOI":"10.1136\/jnnp-2019-322338"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: A review. JAMA. 2020; 323:548-560.","DOI":"10.1001\/jama.2019.22360"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lee JY, Martin-Bastida A, Murueta-Goyena A, Gabilondo I, Cuenca N, Piccini P, Jeon B. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat Rev Neurol. 2022; 18:203-220.","DOI":"10.1038\/s41582-022-00618-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson&apos;s disease. Neurobiol Aging. 2003; 24:197-211.","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Warnecke T, Sch\u00e4fer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson&apos;s disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022; 8:31.","DOI":"10.1038\/s41531-022-00295-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang J, Shi M, Zhang Q, Chen Y, Yin X, Wang X, Zhang Y. Association between constipation and the risk of Parkinson&apos;s disease among participants in the UK Biobank. Neuroepidemiology. 2025; 59:381-390.","DOI":"10.1159\/000540955"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem <i>via<\/i> the vagus nerve. Mol Neurodegener. 2018; 13:21.","DOI":"10.1186\/s13024-018-0257-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bj\u00f6rklund T, Wang ZY, Roybon L, Melki R, Li JY. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014; 128:805-820.","DOI":"10.1007\/s00401-014-1343-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kim S, Kwon SH, Kam TI, <i>et al.<\/i> Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson&apos;s disease. Neuron. 2019; 103:627-641.e7.","DOI":"10.1016\/j.neuron.2019.05.035"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B, Alam AM, Neish AS, Cao X, Ye K. Initiation of Parkinson&apos;s disease from gut to brain by \u03b4-secretase. Cell Res. 2020; 30:70-87.","DOI":"10.1038\/s41422-019-0241-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Limanaqi F, Zecchini S, Ogno P, Artusa V, Fenizia C, Saulle I, Vanetti C, Garziano M, Strizzi S, Trabattoni D, Clerici M, Biasin M. Alpha-synuclein shapes monocyte and macrophage cell biology and functions by bridging alterations of autophagy and inflammatory pathways. Front Cell Dev Biol. 2024; 12:1421360.","DOI":"10.3389\/fcell.2024.1421360"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sampson TR, Debelius JW, Thron T, <i>et al.<\/i> Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&apos;s disease. Cell. 2016; 167:1469-1480.e12.","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease: from basic research to the clinic. Nat Rev Neurol. 2022; 18:476-495.","DOI":"10.1038\/s41582-022-00681-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang L, Cui Y, Han B, Du Y, Salewala KS, Wang S, Zhao W, Zhang H, Wang S, Xu X, Ma J, Zhu Y, Tuo H. Gut microbiota and Parkinson&apos;s disease. Chin Med J (Engl). 2025; 138:289-297.","DOI":"10.1097\/CM9.0000000000003318"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson&apos;s disease patients. Genome Med. 2017; 9:39.","DOI":"10.1186\/s13073-017-0428-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Liang Y, Zhao Y, Fasano A, Su CW. Gut permeability and microbiota in Parkinson&apos;s disease: mechanistic insights and experimental therapeutic strategies. Int J Mol Sci. 2025; 26:9593.","DOI":"10.3390\/ijms26199593"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Radisavljevic N, Metcalfe-Roach A, Cirstea M, Tabusi MM, Bozorgmehr T, Bar-Yoseph H, Finlay BB. Microbiota-mediated effects of Parkinson&apos;s disease medications on Parkinsonian non-motor symptoms in male transgenic mice. mSphere. 2024; 9:e0037923.","DOI":"10.1128\/msphere.00379-23"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ramadan ME, Mostafa TM, Ghali AA, El-Afify DR. Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson&apos;s disease. Inflammopharmacology. 2025; 33:3897-3908.","DOI":"10.1007\/s10787-025-01752-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Leta V, Zinzalias P, Batzu L, <i>et al.<\/i> Effects of a four-strain probiotic on gut microbiota, inflammation, and symptoms in Parkinson&apos;s disease: A randomized clinical trial. Mov Disord. 2025; 40:2710-2721.","DOI":"10.1002\/mds.70047"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wang J, Xue L, Zhang M, Shen P, Zhao W, Tong Q, Wu S, Dai W, Yang X, Wang H. Colonoscopic fecal microbiota transplantation for mild-to-moderate Parkinson&apos;s disease: a randomized controlled trial. Brain Behav Immun. 2025; 130:106086.","DOI":"10.1016\/j.bbi.2025.106086"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. DuPont HL, Suescun J , Jiang ZD, Brown EL, Essigmann HT, Alexander AS, DuPont AW, Iqbal T, Utay NS, Newmark M, Schiess MC. Fecal microbiota transplantation in Parkinson&apos;s disease: a randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol. 2023; 14:1104759.","DOI":"10.3389\/fneur.2023.1104759"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zhang R, Feng R, Wang J, Chen Y, Liu H, Zhu Q, Tian H, Qin C, Teng J, Tang B, Wu M, Zeng J, Wu E, Ding X, Wang X. Gut microbiota modulation <i>via<\/i> repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-na\u00efve Parkinson&apos;s disease: a randomized phase 2 trial. Signal Transduct Target Ther. 2026; 11:94.","DOI":"10.1038\/s41392-026-02604-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Park JC, Chang L, Kwon HK, Im SH. Beyond the gut: decoding the gut-immune-brain axis in health and disease. Cell Mol Immunol. 2025; 22:1287-1312.","DOI":"10.1038\/s41423-025-01333-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shen Q, Liu RT, Wang Y, Zhuang PW, Yang WH, Guo H. Duzhong Fang ameliorates cognitive impairment of Parkinsonian mice by suppressing neuronal apoptotic pathway. Drug Discov Ther. 2024; 18:229-239.","DOI":"10.5582\/ddt.2024.01035"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Li L, Fan S, Zhang W, Li D, Yang Z, Zhuang P, Han J, Guo H, Zhang Y. Duzhong Fang attenuates the POMC-derived neuroinflammation in Parkinsonian mice. J Inflamm Res. 2021; 14:3261-3276.","DOI":"10.2147\/JIR.S316314"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Song L, Yin H, Han R, Li J, Ma N, Wang Y, Guo H. Metabolism of Du Zhong Formula in rats using UPLC-Q-TOF\/MS. J Mass Spectrom. 2022; 57:e4795.","DOI":"10.1002\/jms.4795"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RHW. Progression of Parkinson&apos;s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One. 2010; 5:e8762.","DOI":"10.1371\/journal.pone.0008762"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hajare S, Kulkarni YA. Parkinson&apos;s disease and the gut-brain connection: Unveiling pathways, mechanisms and promising therapies. Brain Res. 2025; 1868:149975.","DOI":"10.1016\/j.brainres.2025.149975"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Jin X, Wei J, Min X, Fan Y, Yuan Z, Du Z, Su Z, Xun T, Du Q, Liang T, He X, Tang W. Gut microbiota and Parkinson&apos;s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective. iScience. 2026; 29:114185.","DOI":"10.1016\/j.isci.2025.114185"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ratajczyk K, Kaczorowska E, Wyka K, Tarasiuk-Zawadzka A, Fichna J, Gajos A. Gut-brain signaling in Parkinson&apos;s disease: a narrative review. Int J Mol Sci. 2026; 27:3531.","DOI":"10.3390\/ijms27083531"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease: the gut-brain axis and environmental factors. Nat Rev Neurol. 2015; 11:625-636.","DOI":"10.1038\/nrneurol.2015.197"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O&apos;Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RHW, Reichmann H. Environmental toxins trigger PD-like progression <i>via<\/i> increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012; 2:898.","DOI":"10.1038\/srep00898"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Camacho M, Greenland JC, Daruwalla C, Scott KM, Patel B, Apostolopoulos D, Ribeiro J, O&apos;Reilly M, Hu MT, Williams-Gray CH. The profile of gastrointestinal dysfunction in prodromal to late-stage Parkinson&apos;s disease. NPJ Parkinsons Dis. 2025; 11:123.","DOI":"10.1038\/s41531-025-00900-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018; 23:716-724.","DOI":"10.1016\/j.chom.2018.05.003"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Heintz-Buschart A, Pandey U, Wicke T, Sixel-D\u00f6ring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P. The nasal and gut microbiome in Parkinson&apos;s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 2018; 33:88-98.","DOI":"10.1002\/mds.27105"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Hummerich R, Schloss P. Serotonin: more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin. Neurochem Int. 2010; 57:67-75.","DOI":"10.1016\/j.neuint.2010.04.020"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wei L, Singh R, Ghoshal UC. Enterochromaffin cells-gut microbiota crosstalk: underpinning the symptoms, pathogenesis, and pharmacotherapy in disorders of gut-brain interaction. J Neurogastroenterol Motil. 2022; 28:357-375.","DOI":"10.5056\/jnm22008"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Jinsmaa Y, Cooney A, Sullivan P, Sharabi Y, Goldstein DS. The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein. Neurosci Lett. 2015; 590:134-137.","DOI":"10.1016\/j.neulet.2015.01.064"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Tripathi AS, Fatima N, Tripathi P, Tripathi R, Alka, Zaki MEA, Mohapatra L, Yasir M, Maurya RK. Beneficial effect of 5-HT1b\/1d agonist on Parkinson&apos;s disease by modulating glutamate and reducing deposition of \u03b1-synuclein. J Biochem Mol Toxicol. 2024; 38:e23627.","DOI":"10.1002\/jbt.23627"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Shearer LJ, Petersen NO, Woodside MT. Internalization of \u03b1-synuclein oligomers into SH-SY5Y cells. Biophys J. 2021; 120:877-885.","DOI":"10.1016\/j.bpj.2020.12.031"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Miquel-Rio L, Sarri\u00e9s-Serrano U, Pavia-Collado R, Meana JJ, Bortolozzi A. The role of \u03b1-synuclein in the regulation of serotonin system: physiological and pathological features. Biomedicines. 2023; 11:541.","DOI":"10.3390\/biomedicines11020541"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Samur DN, Y\u0131ld\u0131r\u0131m S, Maytalman E, Kalay M, Tanr\u0131\u00f6ver G, \u00d6zbey G. Vortioxetine attenuates rotenone-induced enteric neuroinflammation <i>via<\/i> modulation of the TLR2\/S100B\/RAGE signaling pathway in a rat model of Parkinson&apos;s disease. Neuropharmacology. 2025; 271:110385.","DOI":"10.1016\/j.neuropharm.2025.110385"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/20\/4\/20_2026.01045\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:30:14Z","timestamp":1790397014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/20\/4\/20_2026.01045\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2026.01045","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"2026.01045"}}